MedPath

Noninvasive Hemoglobin Testing, Prospective Blood Donors

Not Applicable
Completed
Conditions
Healthy
Anemia
Interventions
Device: Rad-67 Pulse oximeter & DCI Mini sensor
Registration Number
NCT04450381
Lead Sponsor
Masimo Corporation
Brief Summary

The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
131
Inclusion Criteria
  • At least 18 years of age
  • Weight at least 110 pounds
  • Subjects with the intention of being screened for eligibility to donate blood
  • The subject has given written informed consent to participate in the study
Exclusion Criteria
  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
  • Subjects unwilling and/or unable to remove nail polish or acrylic nails
  • Subjects with blood cancers such as leukemia
  • Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia
  • Subjects with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
  • Subjects with self-disclosed/known pregnancy at the time of enrollment
  • Subjects deemed not suitable for the study at the discretion of the investigator
  • Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test subjectsRad-67 Pulse oximeter & DCI Mini sensorAll subjects are enrolled and receive Rad-67 Pulse oximeter \& DCI Mini sensor for measurement of hemoglobin.
Primary Outcome Measures
NameTimeMethod
Rad-67 SensitivityUp to one hour per subject

Sensitivity of the the Rad-67 will be determined for its use in a blood donation center

Rad-67 SpecificityUp to one hour per subject

Specificity of the the Rad-67 will be determined for its use in a blood donation center

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Blood Bank - Site 1

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath